tiprankstipranks
Trending News
More News >
Cumberland Pharmaceuticals Inc (CPIX)
NASDAQ:CPIX
US Market

Cumberland Pharmaceuticals (CPIX) Income Statement

Compare
226 Followers

Cumberland Pharmaceuticals Income Statement

Last quarter (Q3 2025), Cumberland Pharmaceuticals's total revenue was $8.29M, a decrease of -8.73% from the same quarter last year. In Q3, Cumberland Pharmaceuticals's net income was $-1.94M. See Cumberland Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 37.87M$ 39.55M$ 42.01M$ 35.99M$ 37.44M
Gross Profit
$ 31.28M$ 33.49M$ 32.89M$ 27.17M$ 28.79M
Operating Expenses
$ 37.71M$ 43.04M$ 38.60M$ 34.85M$ 35.17M
Depreciation and Amortization
$ 6.04M$ 8.10M$ 5.33M$ 4.61M$ 4.75M
EBITDA
$ 182.42K$ 2.49M$ 332.92K$ -857.83K$ -1.56M
Operating Income
$ -6.43M$ -9.55M$ -5.70M$ -7.68M$ -6.38M
Other Income/Expenses
$ -33.98K$ 3.27M$ 123.74K$ 2.12M$ -188.28K
Pretax Income
$ -6.47M$ -6.28M$ -5.58M$ -5.56M$ -6.57M
Net Income
$ -6.48M$ -6.28M$ -5.57M$ -3.51M$ -3.34M
Per Share Metrics
Basic EPS
$ -0.46$ -0.44$ -0.38$ -0.24$ -0.22
Diluted EPS
$ -0.46$ -0.44$ -0.38$ -0.24$ -0.22
Weighted Average Shares Outstanding
14.06M 14.30M 14.56M 14.90M 15.16M
Weighted Average Shares Outstanding (Diluted)
14.06M 14.30M 14.56M 14.90M 15.16M
Currency in USD

Cumberland Pharmaceuticals Earnings and Revenue History